KRMD · Insider Trading
KORU Medical Systems, Inc. Common Stock (DE)
Every open-market purchase and sale reported by KRMD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Donna French | Director | A | +5,119 | +$15.00K |
| 2026-10-01 | Edward Wholihan | Director | A | +5,119 | +$15.00K |
| 2026-10-01 | R John Fletcher | Director | A | +7,679 | +$22.50K |
| 2026-10-01 | Robert Cascella | Director | A | +5,119 | +$15.00K |
| 2026-10-01 | Shahriar Matin | Director | A | +5,119 | +$15.00K |
| 2026-10-01 | Horton Capital Partners, LLC | 10%+ Owner | A | +5,119 | — |
| 2026-09-09 | Adam R Kalbermatten | Chief Commercial Officer | Buy | +32,000 | +$101.12K |
| 2026-08-06 | Adam R Kalbermatten | Chief Commercial Officer | MIXED | +49,517 | −$108.56K |
| 2026-07-13 | Adam R Kalbermatten | President and CEO | A | +284,091 deriv. | — |
| 2026-07-02 | Adam R Kalbermatten | President and CEO | A | +286,697 deriv. | — |
| 2026-07-01 | Robert Cascella | Director | A | +3,571 | +$15.00K |
| 2026-07-01 | Edward Wholihan | Director | A | +3,571 | +$15.00K |
| 2026-07-01 | Donna French | Director | A | +3,571 | +$15.00K |
| 2026-07-01 | Shahriar Matin | Director | A | +3,571 | +$15.00K |
| 2026-07-01 | Horton Capital Management, LLC | 10%+ Owner | A | +3,571 | — |
| 2026-07-01 | R John Fletcher | Director | A | +5,357 | +$22.50K |
| 2026-06-15 | Adam R Kalbermatten | President-Chief Commercial Off | Buy | +12,500 | +$49.27K |
| 2026-05-20 | Linda M Tharby | Chief Executive Officer | Buy | +1,191 | +$4.67K |
| 2026-05-20 | Linda M Tharby | Chief Executive Officer | Buy | +1,191 | +$1.42M |
| 2026-05-20 | Eric Schiller | Chief Technology Officer | Buy | +5,000 | +$19.56K |
| 2026-05-19 | Linda M Tharby | Chief Executive Officer | MIXED | +6,651 | −$28.86K |
| 2026-05-18 | Christopher Pazdan | Chief Operating Officer | Buy | +5,000 | +$19.40K |
| 2026-05-18 | Thomas Edward Adams | Chief Financial Officer | MIXED | +5,293 | −$11.43K |
| 2026-05-18 | Christopher Pazdan | Chief Operating Officer | MIXED | +3,857 | −$5.79K |
| 2026-05-18 | Thomas Edward Adams | Chief Financial Officer | Buy | +5,500 | +$21.25K |
| 2026-04-06 | Horton Capital Management, LLC | 10%+ Owner | A | +3,472 | — |
| 2026-04-01 | Edward Wholihan | Director | A | +3,472 | +$15.00K |
| 2026-04-01 | Shahriar Matin | Director | A | +3,472 | +$15.00K |
| 2026-04-01 | Robert Cascella | Director | A | +3,472 | +$15.00K |
| 2026-04-01 | R John Fletcher | Director | A | +5,208 | +$22.50K |
| 2026-04-01 | Donna French | Director | A | +3,472 | +$15.00K |
| 2026-04-01 | Joseph M. Manko Jr. | Director | A | +3,472 | — |
| 2026-03-18 | Linda M Tharby | Chief Executive Officer | MIXED | +10,212 | −$24.64K |
| 2026-03-18 | Christopher Pazdan | Chief Operating Officer | MIXED | +3,436 | −$6.97K |
| 2026-03-18 | Thomas Edward Adams | Chief Financial Officer | MIXED | +3,281 | −$9.09K |
| 2026-03-18 | Adam R Kalbermatten | President-Chief Commercial Off | A | +157,975 deriv. | — |
| 2026-02-13 | Horton Capital Partners, LLC | 10%+ Owner | J | −488,071 | — |
| 2026-01-15 | Eric Schiller | Chief Technology Officer | A | +76,426 | — |
| 2026-01-06 | Thomas Edward Adams | Chief Financial Officer | A | +75,000 deriv. | — |
| 2026-01-05 | Horton Capital Partners, LLC | 10%+ Owner | MIXED | −14,419 | — |
| 2026-01-02 | R John Fletcher | Director | A | +3,872 | +$22.50K |
| 2026-01-02 | Donna French | Director | A | +2,581 | +$15.00K |
| 2026-01-02 | Shahriar Matin | Director | A | +2,581 | +$15.00K |
| 2026-01-02 | Edward Wholihan | Director | A | +2,581 | +$15.00K |
| 2026-01-02 | Robert Cascella | Director | A | +2,581 | +$15.00K |
| 2025-11-26 | Horton Capital Management, LLC | 10%+ Owner | J | −41,000 | — |
| 2025-10-20 | Linda M Tharby | President and CEO | A | +29,463 | +$120.21K |
| 2025-10-02 | R John Fletcher | Director | A | +5,874 | +$22.50K |
| 2025-10-02 | Shahriar Matin | Director | A | +3,916 | +$15.00K |
| 2025-10-02 | Robert Cascella | Director | A | +3,916 | +$15.00K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Horton Capital Partners Fund, L.P. | 10%+ Owner | 6,388,877 | $20.64M |
| Horton Capital Partners, LLC | 10%+ Owner | 5,857,207 | $18.92M |
| Horton Capital Management, LLC | 10%+ Owner | 5,852,088 | $18.90M |
| Joseph M. Manko Jr. | Director | 5,566,170 | $17.98M |
| Linda M Tharby | Chief Executive Officer | 620,622 | $2.00M |
| Adam R Kalbermatten | Chief Commercial Officer | 394,017 | $1.27M |
| Christopher Pazdan | Chief Operating Officer | 308,988 | $998.03K |
| Thomas Edward Adams | Chief Financial Officer | 308,147 | $995.31K |
| R John Fletcher | Director | 239,836 | $774.67K |
| Shahriar Matin | Director | 106,263 | $343.23K |
| Donna French | Director | 103,633 | $334.73K |
| Robert Cascella | Director | 103,274 | $333.58K |
| Edward Wholihan | Director | 56,431 | $182.27K |
| Eric Schiller | Chief Technology Officer | 5,000 | $16.15K |
| Kenneth E Miller | Chief Commercial Officer | 3,725 | $12.03K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the KRMD quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.